A Study to Test the Efficacy, Safety, and Pharmacokinetics of Rozanolixizumab in Adult Study Participants With Leucine-Rich Glioma Inactivated 1 Autoimmune Encephalitis
Clinical trial NCT04875975 · TERMINATED
Trial details
- NCT number
- NCT04875975
- Sponsor
- UCB Biopharma SRL
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-27
- Primary completion
- 2024-03-08
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.